Communiqués

09/04/25 Transcarent Completes Merger with Accolade AQ
27/03/25 Accolade Stockholders Approve Merger Between Accolade and Transcarent AQ
06/03/25 Accolade Welcomes Oshi Health to Trusted Partner Ecosystem PR
24/02/25 Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction AQ
04/02/25 Accolade Expands Virtual Care to Medicare Beneficiaries Nationwide Through PlushCare Direct-to-Consumer Offering PR
10/01/25 Accolade: Fiscal Q3 Earnings Snapshot AQ
08/01/25 ACCOLADE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Accolade, Inc. - ACCD BU
08/01/25 Transcarent To Acquire Accolade BU
08/01/25 Transcarent To Acquire Accolade GL
16/12/24 Accolade to Announce Fiscal Third Quarter 2025 Financial Results AQ
13/11/24 Accolade To Present at Upcoming Investor Conferences AQ
15/10/24 Accolade Welcomes Renalogic to Trusted Partner Ecosystem PR
08/10/24 Accolade : Announces Results for Fiscal Second Quarter 2025 Form 8 K PU
08/10/24 Accolade : ACCD Q2 FY25 Earnings Presentation PU
08/10/24 Accolade: Fiscal Q2 Earnings Snapshot AQ
08/10/24 Accolade Announces Results for Fiscal Second Quarter 2025 GL
08/10/24 Accolade Announces Results for Fiscal Second Quarter 2025 AQ
18/09/24 Accolade to Announce Fiscal Second Quarter 2025 Financial Results AQ
28/08/24 Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference AQ
22/08/24 First-of-its-kind Healthcare Innovation Provides Synchronized, Customized Whole-Health Strategies PR
07/08/24 Accolade To Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase AQ
27/06/24 Accolade : ACCD Q1 FY25 Earnings Presentation PU
27/06/24 Accolade: Fiscal Q1 Earnings Snapshot AQ
27/06/24 Accolade Announces Results for Fiscal First Quarter 2025 AQ
12/06/24 Accolade to Announce Fiscal First Quarter 2025 Financial Results AQ
Aucun résultat pour cette recherche